|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | A61K 31/4704 | (2006.01) |
| A61K 31/4704 | (2013.01) | ||
| A61K 38/17 | (2006.01) | ||
| A61K 39/395 | (2013.01) | ||
| A61K 39/395 | (2006.01) | ||
| A61P 27/02 | (2018.01) | ||
| A61P 27/02 | (2006.01) | ||
| A61K 38/179 | (2013.01) | ||
| C07K 16/00 | (2006.01) | ||
| C07K2319/30 | (2013.01) | ||
| C07K 16/22 | (2006.01) | ||
| C07K2319/32 | (2013.01) | ||
| C07K 16/22 | (2013.01) | ||
| C07K 16/00 | (2013.01) | ||
| C07K2317/24 | (2013.01) | ||
| C07K2317/76 | (2013.01) |
| (11) | Number of the document | 3886858 |
| (13) | Kind of document | T |
| (96) | European patent application number | 20838435.4 |
| Date of filing the European patent application | 2020-12-18 | |
| (97) | Date of publication of the European application | 2021-10-06 |
| (45) | Date of publication and mention of the grant of the patent | 2022-05-11 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/EP2020/086993 |
| Date | 2020-12-18 |
| (87) | Number | WO 2021/123142 |
| Date | 2021-06-24 |
| (30) | Number | Date | Country code |
| 19218062 | 2019-12-19 | EP | |
| 20156158 | 2020-02-07 | EP |
| (72) |
ERIKSSON, Helena , SE
KAYE, Joel , IL
TÖRNGREN, Marie , SE
|
| (73) |
Active Biotech AB ,
Box 724, 220 07 Lund,
SE
|
| (54) | COMPOUNDS FOR TREATMENT OF EYE DISEASES ASSOCIATED WITH EXCESSIVE VASCULARISATION |
| COMPOUNDS FOR TREATMENT OF EYE DISEASES ASSOCIATED WITH EXCESSIVE VASCULARISATION |